Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8952136 Antibodies to human programmed death receptor PD-1

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
December 19, 2012
Date of Patent
February 10, 2015
Patent Application Number
13719756
Patent Citations Received
‌
US Patent 12123003 Synthetic RIG-I-like receptor agonists
0
‌
US Patent 12077761 Systems and methods for genetic manipulation of
0
‌
US Patent 12121565 Methods of treatment of specific cancers with NLRP3 inhibitors and anti-PD1/PD-L1 antibodies
0
‌
US Patent 11655303 Anti-CD39 antibody compositions and methods
0
‌
US Patent 11661453 Combination therapies for treating cancer with niraparib and PD-1 inhibitors
0
‌
US Patent 11708412 Methods for treating hematologic cancers
0
‌
US Patent 11802155 ILT-binding agents and methods of use thereof
‌
US Patent 11801240 Combination therapies and uses thereof
‌
US Patent 11827704 Antibody molecules to PD-1 and uses thereof
0
‌
US Patent 11840571 Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8952136
Patent Primary Examiner
‌
Ilia Ouspenski

Find more entities like US Patent 8952136 Antibodies to human programmed death receptor PD-1

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.